Chronic norovirus infection in a patient with a past history of Burkitt lymphoma

被引：0

作者：

Bruggink L.D. ^{[1
]}

Hayes L. ^{[2
]}

Marshall J.A. ^{[1
]}

机构：

[1] Victorian Infectious Diseases Reference Laboratory, Doherty Institute, 792 Elizabeth St, Melbourne, 3000, VIC

[2] Northern Hospital, 185 Cooper St, Epping, 3076, VIC

来源：

VirusDisease | 2015年 / 26卷 / 3期

关键词：

Burkitt lymphoma; Chronic excretion; Immunocompromised; Norovirus;

D O I：

10.1007/s13337-015-0275-7

中图分类号：

学科分类号：

摘要：

The noroviruses are a leading cause of gastroenteritis worldwide. Although the illness is normally mild and self-limiting, there is a growing literature documenting the chronic excretion of norovirus in the immunocompromised. The aim of the current study was to examine the molecular features of chronic norovirus excretion in an immunocompromised patient with a past history of Burkitt lymphoma. During the 241 day course of the study from December 2013 to August 2014, seven faecal specimens were collected from the patient, tested for norovirus by RT-PCR and further analysed in the open reading frame (ORF) 1 and ORF 2 regions. All seven specimens were positive for norovirus by RT-PCR. Molecular sequencing in the polymerase (ORF 1) and capsid (ORF 2) regions indicated that the norovirus could be classified as GII.4 (2006b)/GII.4 (unknown). No significant mutation was found in the ORF 1 or ORF 2 regions analysed over the period of the study. The current report appears to be the first to document chronic norovirus excretion in a patient with a past history of Burkitt lymphoma. It is also the first to indicate long term norovirus excretion in a given individual need not involve major genetic change in key regions of the genome. © 2015, Indian Virological Society.

引用

页码：207 / 210

页数：3

共 14 条

[1]

Bruggink L.D., Oluwatoyin O., Sameer R., Witlox K.J., Marshall J.A., Molecular and epidemiological features of gastroenteritis outbreaks involving genogroup I norovirus in Victoria, Australia, 2002–2010, J Med Virol, 84, pp. 1437-1448, (2012)

[2]

Bruggink L.D., Dunbar N.L., Marshall J.A., Emergence of GII.e as a major ORF 1 norovirus genotype and its associated ORF 2 GII.4 variant forms, Infect Genet Evol, 22, pp. 157-163, (2014)

[3]

Bruggink L.D., Marshall J.A., Molecular and epidemiological features of GIIb norovirus outbreaks in Victoria, Australia, 2002–2005, J Med Virol, 81, pp. 1652-1660, (2009)

[4]

Carlsson B., Lindberg A.M., Rodriguez-Diaz J., Hedlund K.-O., Persson B., Svensson L., Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection, J Gen Virol, 90, pp. 432-441, (2009)

[5]

Engelen M.A., Gunia S., Stypmann J., Elimination of norovirus in a chronic carrier under immunosuppression after heart transplantation- effect of everolimus, Transpl Int, 24, 11, pp. 102-103, (2011)

[6]

Green K.Y., Caliciviridae: the noroviruses, Fields virology, pp. 582-608, (2013)

[7]

Green K.Y., Norovirus infection in immunocompromised hosts, Clin Microbiol Infect, 20, pp. 717-723, (2014)

[8]

Hoffmann D., Hutzenthaler M., Seebach J., Panning M., Umgelter A., Menzel H., Protzer U., Metzler D., Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients, Infect Genet Evol, 12, pp. 461-466, (2012)

[9]

Kroneman A., Vega E., Vennema H., Vinje J., White P.A., Hansman G., Green K., Martella V., Katayama K., Koopmans M., Proposal for a unified norovirus nomenclature and genotyping, Arch Virol, 158, pp. 2059-2068, (2013)

[10]

Kroneman A., Vennema H., Deforche K., v d Avoort H., Penaranda S., Oberste M.S., Vinje J., Koopmans M., An automated genotyping tool for enteroviruses and noroviruses, J Clin Virol, 51, pp. 121-125, (2011)

← 1 2 →